Combined central retinal arterial and venous obstruction: Emergency ophthalmic arterial fibrinolysis

Radiology

Volumn 223, Issue 2, 2002, Pages 351-359

  Vallée, Jean Noël ^a   Paques, Michel ^a   Aymard, Armand ^a   Massin, Pascale ^a   Santiago, Pierre Yves ^a   Adeleine, Patrice ^a   Gaudric, Alain ^a   Merland, Jean Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Eye, abnormalities; Eye, hemorrhage; Retina; Urokinase

Indexed keywords

UROKINASE;

ADULT; AGED; ARTICLE; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MALE; OPHTHALMIC ARTERY; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA VEIN OCCLUSION; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE;

EID: 0036239087     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2232010423     Document Type: Article

References (33)

1. A case of central retinal venous occlusion associated with retinal artery insufficiency
2. Visual recovery in combined central artery and central vein occlusion
3. A case of central retinal vein occlusion accompanied by central retinal artery occlusion
4. Central retinal vein occlusion associated with arterial insufficiency
5. Combined central retinal artery-central vein obstruction
6. Combined occlusion of the central retinal artery and vein
7. Simultaneous occlusion of the central retinal artery and vein
8. Superselective ophthalmic arterial fibrinolysis with urokinase for recent severe central retinal venous occlusion: Initial experience
9. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions
10. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases
11. Anti-cardiolipin-antikorper bei gefassverschlussen am auge
12. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: A population controlled study
13. Systemic associations of retinal vein occlusion
14. Risk factors for retinal vein occlusions
15. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
16. Platelet-active drugs: The relationships among dose, effectiveness, and side effects
17. Natural history and clinical management of central retinal vein occlusion: The Central Vein Occlusion Study Group
18. A prospective study of acute central retinal artery obstruction
19. Experimental central retinal vein occlusion
20. Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases
21. Experimental retinal vascular occlusion: Pathogenesis of central retinal vein occlusion
22. Treatment of central retinal vein occlusion
23. Anticoagulant therapy in occlusive vascular disease of the retina
24. Anticoagulant treatment of occlusion of the central vein of the retina
25. Streptokinase in central retinal vein occlusion: A controlled clinical trial
26. Thrombolytic therapy for central retinal vein occlusion: Results of a pilot study
27. Local intra-arterial thrombolysis in acute ischemic stroke
28. Acute stroke intervention with intraarterial urokinase infusion
29. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease
30. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery
31. Antithrombotic and thrombolytic therapy for ischemic stroke
32. Antithrombotic therapy for venous thromboembolic disease
33. Experimental retinal vascular occlusion. II. A clinico-pathologic correlative study of simultaneous occlusion of central retinal vein and artery